BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanda T, Nakamoto S, Wu S, Nakamura M, Jiang X, Haga Y, Sasaki R, Yokosuka O. Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus. J Clin Transl Hepatol 2015;3:205-10. [PMID: 26623267 DOI: 10.14218/JCTH.2015.00016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Migueres M, Lhomme S, Izopet J. Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment. Viruses 2021;13:1900. [PMID: 34696330 DOI: 10.3390/v13101900] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
2 Kanda T, Sasaki R, Masuzaki R, Takahashi H, Mizutani T, Matsumoto N, Nirei K, Moriyama M. Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease. Int J Mol Sci 2020;21:E6384. [PMID: 32887515 DOI: 10.3390/ijms21176384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
3 Kanda T, Sasaki R, Masuzaki R, Matsumoto N, Ogawa M, Moriyama M. Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection. Viruses 2020;12:E533. [PMID: 32408660 DOI: 10.3390/v12050533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
4 Setyowati D, Mubawadi T, Mirasa YA, Purwanto D, Amin M, Utsumi T, Soetjipto S, Juniastuti J, Lusida MI. Molecular epidemiology of hepatitis A outbreaks in two districts in Indonesia in 2018: Same subtype, but different strains. Biomed Rep 2020;12:51-8. [PMID: 31929874 DOI: 10.3892/br.2019.1261] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Jiang W, Ma P, Long G. A visualizable hepatitis A virus and hepatitis C virus coinfection model in vitro: coexistence of two hepatic viruses under limited competition in viral RNA synthesis.. [DOI: 10.1101/709071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Kaneko T, Kanda T, Matsuoka S, Moriyama M. Nutritional Treatment of Liver Disease. Nichidai Igaku Zasshi 2019;78:231-236. [DOI: 10.4264/numa.78.4_231] [Reference Citation Analysis]
7 Win NN, Kanda T, Nakamoto S, Moriyama M, Jiang X, Suganami A, Tamura Y, Okamoto H, Shirasawa H. Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression. Int J Med Sci 2018;15:1153-9. [PMID: 30123052 DOI: 10.7150/ijms.27489] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
8 Gupta SP. Hepatitis Therapy. Studies on Hepatitis Viruses 2018. [DOI: 10.1016/b978-0-12-813330-9.00004-1] [Reference Citation Analysis]
9 Nguyen KT, Han SB. Hepatitis A and Hepatitis E. Handbook of Liver Disease 2018. [DOI: 10.1016/b978-0-323-47874-8.00003-1] [Reference Citation Analysis]
10 Jiang X, Kanda T, Haga Y, Sasaki R, Nakamura M, Wu S, Nakamoto S, Shirasawa H, Okamoto H, Yokosuka O. Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication. Exp Ther Med 2017;13:3305-8. [PMID: 28587404 DOI: 10.3892/etm.2017.4407] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]